Pacific Biosciences
PACB
PACB
245 hedge funds and large institutions have $4.83B invested in Pacific Biosciences in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 97 increasing their positions, 77 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less call options, than puts
Call options by funds: $31.8M | Put options by funds: $47.5M
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
36% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 39
Holders
245
Holding in Top 10
4
Calls
$31.8M
Puts
$47.5M
Top Buyers
| 1 | +$105M | |
| 2 | +$76.4M | |
| 3 | +$66.9M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$57.3M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$57.3M |
Top Sellers
| 1 | -$44.5M | |
| 2 | -$43.6M | |
| 3 | -$34.1M | |
| 4 |
Two Sigma Investments
New York
|
-$15.1M |
| 5 |
Renaissance Technologies
New York
|
-$14M |